ArticleJournal of plastic and reconstructive surgery2026
Development and Validation of the Japanese Versions of the Eye and HRQOL Modules of FACE-Q Aesthetics for Patients Who Undergo Blepharoptosis Surgery.
Article in Journal of plastic and reconstructive surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The face is an important factor for an individual to create an impression and engage in social activities such as seeing, talking, laughing, and eating. Treatment for people with blepharoptosis is covered under public health insurance in Japan. Many surgeons report that the operation improves patients' health-related quality of life (HRQOL); however, no patient-reported outcome (PRO) measures regarding the face and eyelids are available in Japanese. Therefore, this study developed the Japanese versions of the Eye and HRQOL Modules of FACE-Q Aesthetics and analyzed their validity and reliability. Methods: We translated FACE-Q Aesthetics following the procedure established by the copyright department of Q-Portfolio after obtaining permission to develop the Japanese version. Subsequently, we validated the translated modules by surveying 50 patients with blepharoptosis. Data were collected in the following three waves: preoperatively, 6 months postoperatively, and 2 weeks after the second phase. Data were analyzed to identify floor and ceiling effects, internal consistency, test-retest reliability, and concurrent validity. Results: No problematic floor or ceiling effects were identified. The non-response rate for all items was ≤10%. Cronbach's alpha coefficients were >0.7 for all scales. Moreover, the intraclass correlation coefficient between the first and second postoperative responses was also >0.7 for all scales. Several correlations were observed among the other PRO measures, which are available in Japanese. Conclusions: This study developed and validated the Japanese versions of the Eye and HRQOL Modules of FACE-Q Aesthetics. These versions were sufficiently valid, reliable, and in line with Japanese culture.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.